AstraZeneca, CR Capital Magament and Panlin capital led a $50m Series B round in NuProbe, a biotechnology company, with participation from Gaorong Capital, Deguan Capital, Pappas Capital, BioTrack Capital, Sequoia, Yonghua Capital and Tuobang Capital.